Different symptomatic improvement pattern revealed by factor analysis between placebo response and response to Esketamine in treatment resistant depression-Reference-Cited by-同舟云学术

Different symptomatic improvement pattern revealed by factor analysis between placebo response and response to Esketamine in treatment resistant depression

Published:2022-06-09 Issue:8 Volume:76 Page:377-383
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin Neurosci

Author:

Ohnishi Takashi¹^ORCID,Wakamatsu Akihide¹,Kobayashi Hisanori²

Affiliation:

1. Medical Affairs Division Janssen Pharmaceutical K.K. Tokyo Japan

2. Research and Development, Clinical Science Division Janssen Pharmaceutical K.K. Tokyo Japan

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13379

Reference27 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Evolving Issues in the Treatment of Depression

3. Meta-Regression Analysis of Placebo Response in Antipsychotic Trials, 1970–2010

4. Differential Effectiveness of Placebo Treatments

5. Another face of placebo: The lessebo effect in Parkinson disease: Meta-analyses

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression;European Journal of Clinical Pharmacology;2023-12-20

2. Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis;Neuropsychiatric Disease and Treatment;2023-03